Source: Eur Respir J 2011; 37: 978-981



Rating:

Share or cite this content

Citations should be made in the following way:
Raviglione M.C., Lange C., Migliori G.B.. Preventing and managing antimicrobial resistance: imperative for chest physicians. Eur Respir J 2011; 37: 978-981

Member's Comments

No comment yet.

Related content which might interest you: Prescribing and guidelines: both must improve to combat antimicrobial resistance Source: Eur Respir J 2011; 37: 9-11 Year: 2011 Prescribing and guidelines: both must improve to combat antimicrobial resistance Source: Eur Respir J 2012; 39: 1050 Year: 2012 Optimising COPD prevention: what do the doctors need? Source: Annual Congress 2007 - Smoking and the lung Year: 2007 International guidelines for nosocomial pneumonia: do they cover multidrug resistance management? Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution Year: 2019 Rational use and stewardship of antibiotics in pediatric respiratory disease Source: ERS Courses: Paediatric respiratory infections Year: 2019 Fate or missed opportunities - challenges in diagnosing paediatric drug resistant tuberculosis in Germany Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 Antibiotic use and misuse in the community: how to manage the problem Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Point of care testing and antibotic prescription for lower respiratory tract infections: what does the GP need to know? Source: Annual Congress 2012 - Primary Care Programme Year: 2012 Antibiotic prescribing in acute respiratory infections – are we following guidelines? Source: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006 Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020 Year: 2021 A clinical and aetiological evaluation of community acquired pneumonia-are we following guidelines in prescribing antibiotics? Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Invasive diagnostics and endoscopic interventions: the chest physician’s arsenal Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 Chest radiography and pneumonia in primary care: diagnostic yield and consequences for patient management Source: Eur Respir J 2006; 28: 933-938 Year: 2006 Therapeutic strategies in pneumonia: going beyond antibiotics Source: Eur Respir Rev 2015; 24: 516-524 Year: 2015 Point of care respiratory viral testing (POCT): A novel service to target appropriate antimicrobial prescription and improve antibiotic stewardship. Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia Year: 2018 Antibiotic resistance and clinical outcomes: the CAPNETZ experience Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Community acquired pneumonia in elderly people: aetiology and antimicrobial drug susceptibility Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004 Will clinicians keep their place in modern management of tuberculosis? Source: Eur Respir J 2001; 18: Suppl. 33, 474s Year: 2001 Audit of the prescription of antibiotic and oxygen therapy and chest Xray requests in community aquired pneumonia in the medical assessment unit Source: Eur Respir J 2004; 24: Suppl. 48, 229s Year: 2004